Dealmaking

Exclusive: Investcorp-backed Resultant beefs up PE advisory services with Liberty acquisition

Resultant is looking to execute on about one to two add-on deals a year.

Side Letter: Sanctions struggles

In today's edition, Private funds managers are facing rising risks from sanctions; PE's distribution drought is altering allocation behaviour; Why wealth managers and PE owners could prove a perfect marriage.

Motive’s Neil Cochrane sees significant AI opportunity in fund admin; Alantra IM to exit stake in French fund-of-funds manager

Alantra IM has agreed to sell a minority stake in Access Capital Partners.

Agentic AI offers growth opportunities in fund administration

Motive Partners merged fund administrator Alchelyst and tech-enabled client servicing business Lyra in March.

Financial services deep dive, with insights from Carlyle, Charlesbank, GTCR, Motive Partners, Stone Point Capital and Warburg Pincus

The debut of PE Hub's Sector Spotlight series, with the first installment focusing on private equity dealmaking in financial services through conversations with senior dealmakers from Carlyle, Charlesbank, GTCR, Motive Partners, Stone Point Capital and Warburg Pincus.

Bonaccord’s minority stake in Prime Finance underscores interest in multi-asset class strategies

'Pension plans and insurance companies that are investors with us want comprehensive capital solutions in real estate debt, not single-strategy exposure,' Bonaccord's Ajay Chitkara tells PE Hub.

Sector Spotlight: Wealth, insurance and fintech drive thriving PE-backed financial services M&A

PE Hub spoke with senior private equity dealmakers from Carlyle, Charlesbank, GTCR, Motive Partners, Stone Point Capital and Warburg Pincus about the trends driving financial services deals.

Brookfield’s David Nowak: Early strategic education is important for exits; Foresight backs German battery storage business

'One of the things that we try to do is get out to strategics early on in our ownership and educate them over a three- to five-year period.'

‘$1 trillion gap’ attracts private equity to women’s health, says Kearney’s Paula Bellostas Muguerza; Astorg, Cinven, Nordic target pathology assets

Speaking with Kearney’s Paula Bellostas Muguerza about trends driving PE dealmakers to the women's health sector; a look at deals in the pathology sector and the tailwinds behind them; discussing the $1.1 billion sale of EyeSouth Partners to Cencora and the growth of the business under Olympus Partners.

PE targets pathology assets: 5 deals

Astorg, Cinven, Nordic Capital, Consonance and Pike Street are among the firms pursuing transactions in pathology.